Jump to Navigation

Digitek Digoxin Information Center

1. Digitek (digoxin tablets, USP) 125 mcg (0.125 mg), an Rx oral cardiotonic -
a yellow, scored tablet imprinted with a "B" over "145"; single tablet unit dose
blister packs. Packaged as: UD100 tablets (10X10), NDC 51079-945-20; UD 300 tablets (10X30), NDC 51079-945-57; PC300 tablets (10X30), NDC 51079-945-56; and CP180 Patient Compliance Package (6X30), NDC 51079-945-66; Recall # D-291-2008.

2. Digitek (digoxin tablets, USP) 250 mcg (0.25 mg), an Rx oral cardiotonic -
a white, scored tablet imprinted with a "B" over "146"; single tablet unit dose blister packs. Packaged as: UD100 tablets (10x10), NDC 51079-946-20 and CP180 Patient Compliance Package, 180 tablets (6X30), NDC 51079-946-66; Recall # D-292-2008.

CODE & LOT NUMBERS:

1. Lot numbers (digoxin tablets, USP) 125 mcg (0.125 mg): 7A666, exp. 7/08; 7F048, exp. 10/08; 7D352, exp. 12/08; 7P862, exp. 3/09; and 8C515, exp. 9/09; Lot number: 6S406, exp. 5/08; Lot numbers: 7J541, exp. 1/09; 7M709, exp. 3/09; 7P965, exp. 4/09; 8A266, exp. 7/09; and 8C514, exp. 9/09; Lot numbers: 7P964, exp. 4/09 and 8B371, exp. 8/09;

2. Lot numbers (digoxin tablets, USP) 250 mcg (0.25 mg): 6S379, exp. 5/08; 7C971, exp. 9/08; 7J525, exp. 1/09; 7V200, exp. 6/09; Lot numbers: 7P963, exp. 4/09 and 8A332, exp. 7/09

RECALLING MANUFACTURER:

UDL Laboratories, Inc., Rockford, IL, by letter on April 28, 2008. Firm initiated recall is ongoing.

REASON:
Super-Potency; UDL repackaged lots of Digitek digoxin tablets that have been recalled by the manufacturer (Actavis) due to the tablets having a thickness approximately double that of their specification.

VOLUME OF PRODUCT IN COMMERCE:
Approximately 65,242 cartons of 100;

Approximately 4,624 cartons of 300; and

Approximately 86,489 cartons of 180.

DISTRIBUTION:
Nationwide

How Can We Assist You?

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close